Transgenic model of aldosterone-driven cardiac hypertrophy and heart failureWENNING QIN; RUDOLPH, Amy E; BOND, Brian R et al.Circulation research. 2003, Vol 93, Num 1, pp 69-76, issn 0009-7330, 8 p.Article

1-2-(2,2,2-Trifluoroethoxy)ethyl-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitorsTOLLEFSON, Michael B; ACKER, Brad A; JACOBSEN, E. J et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 10, pp 3125-3128, issn 0960-894X, 4 p.Article

Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitorsOWEN, Dafydd R; WALKER, John K; MOLYNEAUX, John M et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 15, pp 4088-4091, issn 0960-894X, 4 p.Article

Investigation of the pyrazinones as PDE5 inhibitors: Evaluation of regioisomeric projections into the solvent regionHUGHES, Robert O; MADDUX, Todd; HAN, Seungil et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 21, pp 6348-6352, issn 0960-894X, 5 p.Article

1-(2-Ethoxyethyl)-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitorsTOLLEFSON, Michael B; ACKER, Brad A; JACOBSEN, E. J et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 10, pp 3120-3124, issn 0960-894X, 5 p.Article

Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulationCOKER, Mytsi L; JOLLY, Jennifer R; JOFFS, Cassandra et al.American journal of physiology. Heart and circulatory physiology. 2001, Vol 50, Num 2, pp H543-H551, issn 0363-6135Article